MedPath

UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States
Ownership
-
Established
1969-01-01
Employees
2K
Market Cap
-
Website
http://www.uab.edu

Influence of Ambient Temperature on Office Behaviors

Not Applicable
Completed
Conditions
Obesity
Interventions
Other: thermostat
First Posted Date
2015-07-23
Last Posted Date
2015-11-10
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
25
Registration Number
NCT02507310
Locations
🇺🇸

University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, United States

ENABLE CHF-PC (Comprehensive Heartcare For Patients and Caregivers)

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Behavioral: Usual HF Care
Behavioral: Behavioral Support
First Posted Date
2015-07-22
Last Posted Date
2022-01-18
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
573
Registration Number
NCT02505425
Locations
🇺🇸

Birmingham Veterans Affairs Medical Center (BVAMC), Birmingham, Alabama, United States

🇺🇸

University of Alabama at Birmingham, School of Nursing, Dept. Acute, Chronic and Continuing Care, Birmingham, Alabama, United States

Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease

Phase 2
Completed
Conditions
Chronic Kidney Disease
Albuminuria
Interventions
First Posted Date
2015-07-14
Last Posted Date
2022-12-21
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
21
Registration Number
NCT02497300
Locations
🇺🇸

Hypertension Research Clinic at UAB, Birmingham, Alabama, United States

Investigation of Non-Invasive Outcomes Predictors in Patients Undergoing DBS for Movement Disorders

Completed
Conditions
Movement Disorders
First Posted Date
2015-07-02
Last Posted Date
2018-05-11
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
21
Registration Number
NCT02488837
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Improving Weight Loss Maintenance Through Alternative Schedules of Treatment

Not Applicable
Completed
Conditions
Obesity
Interventions
Behavioral: variable interval schedule
Behavioral: self-directed treatment
First Posted Date
2015-07-01
Last Posted Date
2015-07-01
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
108
Registration Number
NCT02487121

A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)

Completed
Conditions
Cystic Fibrosis
Interventions
Other: Observational
First Posted Date
2015-06-22
Last Posted Date
2020-05-20
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
452
Registration Number
NCT02477319
Locations
🇺🇸

Children's Hospital of Wisconsin, Milwaukee, Wisconsin, United States

🇺🇸

Hershey Medical Center; Penn State Children's Hospital, Hershey, Pennsylvania, United States

🇺🇸

Froedtert Hospital, Milwaukee, Wisconsin, United States

and more 35 locations

Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders

Completed
Conditions
Esophageal Diseases
First Posted Date
2015-06-19
Last Posted Date
2018-03-08
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
18
Registration Number
NCT02476513
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Evaluating the Role of Expectations in Response to Caffeine Consumption: An RCT

Not Applicable
Completed
Conditions
Affect
Caffeine
Cognitive Ability, General
Mood
Interventions
Drug: Placebo
First Posted Date
2015-06-03
Last Posted Date
2017-07-12
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
205
Registration Number
NCT02461693

Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)

Phase 1
Terminated
Conditions
Cerebral Edema
Brain Metastases
Interventions
Other: Placebo
First Posted Date
2015-06-03
Last Posted Date
2022-09-21
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
1
Registration Number
NCT02460874
Locations
🇺🇸

University of Alabama at Birmingham (UAB) Department of Radiation Oncology, Birmingham, Alabama, United States

Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)

Phase 2
Completed
Conditions
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
Interventions
First Posted Date
2015-06-01
Last Posted Date
2020-08-06
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
17
Registration Number
NCT02459119
Locations
🇺🇸

Wayne State University, Detroit, Michigan, United States

🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath